Cidan Jiaonang (慈丹胶囊)慈丹胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 北京勃然制药有限公司Chinese legal name: 北京勃然制药有限公司
主要成分Active Ingredients
- 莪术E Shu
- 山慈菇Shanci Gu
- 鸦胆子Yadan Zi
- 马钱子粉Maqian Zifen
- 蜂房等Fengfang Deng
药物知识说明
莪术是一种在国家药监局注册认定的药品。该药品含有山慈菇、莪术、马钱子粉-73b91d0c等成分。
该药品关联的活性成分包括：山慈菇Shanci Gu、莪术E Shu、马钱子粉Maqian Zifen、鸦胆子Yadan Zi。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：北京勃然制药有限公司Chinese legal name: 北京勃然制药有限公司。
您可以探索含有相同成分的其他药品：山慈菇-48e16586成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 慈丹胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 山慈菇Shanci Gu, 莪术E Shu, 马钱子粉Maqian Zifen, 鸦胆子Yadan Zi.
Manufacturers recorded for this product: 北京勃然制药有限公司Chinese legal name: 北京勃然制药有限公司.
Explore other medicines containing the same ingredient: 山慈菇 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 慈丹胶囊Recorded Chinese name: 慈丹胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 0.27g*60粒0.27 g × 60 capsules
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 北京勃然制药有限公司Chinese legal name: 北京勃然制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字Z20063914
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字Z20063914
Manufacturer
Chinese legal name: 北京勃然制药有限公司 (domestically manufactured)
Traditional functions
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
0.27 g × 60 capsules
中文说明书原文Original Chinese source label
批准文号
国药准字Z20063914
生产企业
北京勃然制药有限公司(国产)
功能主治
化瘀解毒，消肿散结，益气养血，用于原发性肝癌等恶性肿瘤或经手术，放化疗后患者的辅助治疗。适用于原发性肝癌瘀毒蕴结证，能直接杀灭肝癌细胞，促使癌瘤退化、缩小、消失；又能提高人体免疫功能与造血功能，增强人体的抗病能力。与西医配合用于癌症病人的术后和放疗、化疗中，能增强放疗、化疗、巩固手术治疗的效果，有效地防止肝癌细胞转移或扩散，可改善临床症状，提高病灶缓解率。还能减轻放疗、化疗的副作用。预防控制肿瘤复发与转移，延长生命。
用法用量
口服，一次5粒，一日4次，一个月为一疗程，或遵医嘱。
不良反应
偶见服药后恶心。
禁忌
孕妇禁用。
注意事项
本品含马钱子、鸦胆子等，不可超量服用。运动员慎用。
贮藏
密封干燥处。
规格
0.27g*60粒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.